Joel Schuman

About Joel Schuman

Joel Schuman

Chair, Department of Ophthalmology, NYU Langone Medical Center, New York

In 2001, Schuman and his team were the first to identify a molecular marker for human glaucoma, and, along with his colleagues Eric Swanson, James Fujimoto, Carmen Puliafito and David Huang, he invented OCT technology – receiving the Champalimaud Award for it. An NEI-funded principal investigator since 1995, his current research interests include imaging of the eye, laser-tissue interactions, aqueous outflow, and ocular pharmacology.